Drug name - Gleevec

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6958335

(Pediatric)

NOVARTIS Treatment of gastrointestinal stromal tumors
Jun, 2022

(5 months ago)

Drugs and Companies using IMATINIB MESYLATE ingredient

Market Authorisation Date: 10 May, 2001

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 50MG BASE CAPSULE;ORAL Discontinued
EQ 100MG BASE CAPSULE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in